Impact of Hemoglobin A1C on Diabetic Patients Undergoing Elective Surgery by Thomas, Ethan
University of North Dakota 
UND Scholarly Commons 
Nursing Capstones Department of Nursing 
Spring 5-15-2020 




Follow this and additional works at: https://commons.und.edu/nurs-capstones 
 Part of the Nursing Commons 
Recommended Citation 
Thomas, Ethan, "Impact of Hemoglobin A1C on Diabetic Patients Undergoing Elective Surgery" (2020). 
Nursing Capstones. 310. 
https://commons.und.edu/nurs-capstones/310 
This Independent Study is brought to you for free and open access by the Department of Nursing at UND Scholarly 
Commons. It has been accepted for inclusion in Nursing Capstones by an authorized administrator of UND 








Impact of Hemoglobin A1C on Diabetic Patients Undergoing Elective Surgery 
 
Ethan Thomas, RN, BSN, CEN 
Family Nurse Practitioner Program, University of North Dakota 
NURS 997: Independent Study 
  
IMPACT OF HEMOGLOBIN A1C ON DIABETIC PATIENTS UNDERGOING ELECTIVE SURGERY
   
2 
PERMISSION 
Title  Impact of Hemoglobin A1C on Diabetic Patients Undergoing Elective Surgery 
Department Nursing 
Degree Master of Science 
 
In presenting this independent study in partial fulfillment of the requirements for a graduate 
degree from the University of North Dakota, I agree that the College of Nursing & Professional 
Disciplines of this University shall make if freely available for inspection. I further agree that 
permission for extensive copying or electronic access for scholarly purposes may be granted by 
the professor who supervised my independent study work or, in his/her absence, by the 
chairperson of the department or the dean of the Graduate School. It is understood that any 
copying or publication or other use of this independent study or part thereof for financial gain 
shall not be allowed without my written permission. It is understood that due recognition shall 
be given to me and to the University of North Dakota in any scholarly use which may be made 
of any material in my independent study.  
 
 
Signature       
Date  03/22/2020    
 
  
IMPACT OF HEMOGLOBIN A1C ON DIABETIC PATIENTS UNDERGOING ELECTIVE SURGERY
   
3 
Abstract 
Diabetes is the most common endocrine disease in the United States and has a profound 
impact on the quality of human life (Sreedharan & Abdelmalak, 2018). There is no doubt that 
clinicians will encounter diabetic patients at some point in their professional career. Diabetes is 
an important cause of morbidity in the adult population and results in hyperglycemia, 
hypoglycemia, renal dysfunction and cardiovascular complications (Sreedharan & Abdelmalak, 
2018). Glycemic control is important for not only slowing the progression of the disease but 
also in reducing the risk of surgical complication. Identification and proactive treatment of 
those with poor glycemic control undergoing elective surgical intervention is important. This 
case report and literature review will highlight how hemoglobin A1C impacts surgical risk in 
diabetic patients undergoing elective surgical intervention. We will also discuss how clinicians 
can use hemoglobin A1C as a guide to identify, manage and treat high-risk diabetic patients to 
improve surgical outcome.  
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Background 
Glycemic control is an important factor to consider when preoperatively assessing 
patients with diabetes undergoing elective surgery. Several studies show that poor glycemic 
control in the perioperative period is associated with several adverse outcomes including 
wound infection, pneumonia, sepsis and cardiovascular events (Simha & Shan, 2019). There is 
limited evidence available showing the importance of optimal glycemic control in preventing 
postoperative morbidity and mortality, decreasing hospital length of stay, and cardiovascular 
complications (Simha & Shan, 2019). Therefore, optimization of glycemic control is worth 
achieving in the preoperative period when possible (Palermo & Garg, 2019). Preoperative 
assessment of hemoglobin A1C helps clinicians to identify, proactively treat, and manage high-
risk diabetic patients undergoing elective surgery (Palermo & Garg, 2019).  
The case report presents a 76-year-old female who comes into the clinic for a 
preoperative evaluation prior to right knee arthroscopy for a meniscal tear suffered 
approximately six months ago. She is a type 2 diabetic and on oral antihyperglycemics. 
Assessment of her glycemic control is an important consideration in this preoperative 
evaluation as we have pointed out that poor glycemic control has been associated with adverse 
surgical outcomes including, what is probably of most concern with this case, surgical site 
infection. Optimizing her glycemic control during this period may help to avoid or reduce the 
risk of postoperative complications. Measurement of her hemoglobin A1C will provide us with a 
good idea of her glycemic control as well as identify her risk for adverse outcomes.  
Hemoglobin A1C reflects average blood glucose over the previous three months and 
allows us to estimate the overall quality of glycemic control (Cheisson et. al, 2018). Simha and 
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Shah (2019) state that hemoglobin A1C should be assessed in all diabetic patients 
preoperatively to assess glycemic control. This allows clinicians to identify diabetic patients at 
higher risk for adverse outcomes so that they can be proactively managed for optimal safety. 
Measures could include postponement of surgery or increased surveillance and treatment 
during various stages of the surgical period (Yang et al., 2016). There are currently guidelines 
for achieving optimal perioperative glucose control, but they lack sufficient detail (Simha & 
Shah, 2019). The purpose of this case report is to highlight how hemoglobin A1C impacts risk 
for elective surgery and how clinicians can use it in the preoperative period to assess glycemic 
control as a predictor of risk as well as how it can be used to guide the safest most effective 
care. 
Case Report 
 The patient is a 76-year-old female who presents to the clinic for a preoperative 
evaluation prior to a right knee arthroscopy for a meniscal tear suffered approximately six 
months ago. She has had ongoing pain in her right knee which is why she has decided to undergo 
elective knee arthroscopy. She plans to complete the surgery in the next thirty days. Her past 
medical history includes hypertension, obesity, type 2 diabetes, hypothyroidism, and squamous 
cell carcinoma. Her past surgical history includes hysterectomy, skin biopsy, and c-section x 2. 
She has allergies to amoxicillin and morphine. Her current medication list includes lisinopril 10 
mg daily, metformin 1000 mg BID, rybelsus 7 mg daily, Synthroid 125 mcg daily, aspirin 81 mg 
daily, Tylenol prn and ibuprofen prn. She has been regularly taking Tylenol 1000 mg TID and 
Ibuprofen 600 mg TID. She is a former smoker one pack per day for twenty years. She does not 
currently smoke. She reports rarely using alcohol and denies any illicit drug use. She denies any 
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problems with bleeding or clotting disorders. She does state that she was told by an 
anesthesiologist once that she was difficult to wake after a surgery and that they think it had 
something to do with her oxygen. She otherwise denies any problems with anesthesia, and there 
were no further complications with that one episode following surgery. Family history is 
significant for coronary artery disease, cancer, hypertension, cerebral vascular accident, 
hyperlipidemia, and obesity. A comprehensive review of systems was reviewed and negative 
except for right knee pain.  
 Her objective assessment this visit reveals a blood pressure of 136/88, pulse 78, 
temperature 98.5, oxygen saturation 95%, height 5’6”, weight 211 lbs., and a BMI of 34. Physical 
exam is unremarkable except for impaired gait related to right knee pain. She does use a walker 
for ambulation. Focused musculoskeletal exam reveals a right lower extremity capillary refill <3 
sec. Right lower extremity circulatory, motor and sensory function are intact. There is full range 
of motion of the right knee. Laboratory results available during this visit include a TSH, CMP, CBC 
with differential and platelets, and an EKG. All labs are within defined limits except for she is 
slightly anemic with an RBC count of 4.49 (4.70-6.10 M/uL). Hemoglobin and hematocrit are 
within defined limits. Her EKG shows a normal sinus rhythm.  
 Her preoperative exam is essentially unremarkable, and she is a good candidate to 
proceed with her surgical procedure. Given her history of type 2 diabetes and the fact that she 
will be having an invasive surgical procedure, we will plan to get a hemoglobin A1C to assess her 
glycemic control to identify risk. Her glucose on CMP today is 98 mg/dL. At this point, there is no 
reason not to continue with surgical intervention. We did counsel on the risks and benefits of the 
surgery she will be undergoing. We discussed that her surgeon will discuss these risks and 
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benefits in greater detail. Medication management regarding which medications to stop and 
which ones she may continue closer to surgery were discussed. All questions were answered, and 
patient was encouraged to contact our office with any further questions or concerns.  
Literature Review 
 A comprehensive literature review was conducted to get a better understanding of how 
hemoglobin A1C impacts risk for diabetic patients undergoing elective surgery. It was also sought 
how clinicians can use hemoglobin A1C to assess glycemic control and how to make decisions 
regarding how to proceed with these patients prior to elective surgery. A detailed search of the 
literature was conducted using the Harley E. French School of Medicine and Health Sciences 
library. PubMed was the library resource used in the literature search. Key terms used were 
“preoperative evaluation” AND “hemoglobin A1C.” This resulted in 193 articles. A filter with 
publication date of articles within the past 5 years was applied and revealed 92 results. From 
here I chose 12 articles that were relevant to my topic of discussion.  
How Does Hemoglobin A1C Impact Risk for Elective Surgery?  
Reich et al. (2019) point out that diabetes mellitus is a risk factor for perioperative 
complications in elective orthopedic surgery (p. 514). In their study, they looked to determine 
the incidence of surgical site infections (SSIs) in diabetic orthopedic trauma patients to establish 
a protocol for managing diabetes in orthopedic trauma patients. This was a retrospective cohort 
study that looked at orthopedic trauma patients who underwent surgical intervention with at 
least one month of follow up. They classified patients as either poorly controlled or well 
controlled based on hemoglobin A1C and blood glucose levels. They then looked at rates of 
surgical site infection among those enrolled in the study and found that trauma patients with 
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poorly controlled diabetes have a higher rate of SSIs compared to those with controlled diabetes. 
Interestingly, they also hypothesized that close postoperative blood glucose monitoring and 
management would lead to fewer SSIs but found that perioperative diabetes control does not 
seem to decrease infection rates in these patients. Thus, this highlights the importance of 
preoperative glycemic optimization when possible.  
 In a study by Cancienne et al. (2017), they looked at patients who underwent elective 
forefoot surgery with diabetes to look at what hemoglobin A1C level could be used as a threshold 
for an increased risk of postoperative surgical site infection following forefoot surgery. They 
found that the risk of postoperative SSI following forefoot surgery increased as the perioperative 
hemoglobin A1C increased. 
A study by Jehan et al. (2018) evaluated the impact of hemoglobin A1C level on outcomes 
after emergency general surgery. The study found that patients with an elevated hemoglobin 
A1C and a postoperative random blood sugar >200 mg/dl have a four times higher risk of 
developing major complications after emergency general surgery. They suggest that a 
preoperative hemoglobin A1C can identify patients prone to develop postoperative 
hyperglycemia, regardless of their preoperative random blood sugar. 
Preoperative Evaluation 
Clinicians often use hemoglobin A1C to assess average glycemic control in the 
preoperative evaluation. This helps to identify patients at increased risk for postoperative 
complications so that decisions can be made on how to proceed and/or manage patients prior to 
elective surgery. It has been found that early preoperative identification of patients with poorly 
controlled diabetes and proactive treatment through various phases of surgery improves 
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glycemic control and lowers the risk of surgical complications and decreases hospital length of 
stay (Palermo & Garg, 2019).   
Palermo & Garg (2019) state that “limited data show the importance of preoperative 
diabetes control to avoid postoperative complications and based on these data and our own 
experience, we suggest that if the opportunity exists to improve glycemic control before surgery, 
it is worth trying to achieve an HbA1c level <8%” (p. 14). It is also advised, that when time permits, 
referral to a diabetes care team be made before surgery as it is helpful because aggressive 
treatment with follow up is often required (Palermo & Garg, 2019). In a study by Garg et al. 
(2018), preoperative diabetes management improved glycemic control on the day of surgery and 
postoperatively and decreased the incidence of hyperglycemia.  
Simha & Shah (2019) recommend that HbA1c be checked preoperatively in all patients 
with diabetes to assess glucose control. They state that “although higher levels (HbA1c) are 
associated with unfavorable outcomes, no evidence shows that postponing surgery to improve 
glucose control is beneficial” and that “perioperative glucose levels have been shown to influence 
surgical outcomes more the hemoglobin A1C” (p. 399). They do, however, recommend “it is 
reasonable to defer elective surgery in patients with a HbA1c >8% if the situation will intensify 
diabetes management strategies” (p.399). Conditions that warrant postponement of surgery 
include severe hyperglycemia (>250 mg/dL) with or without metabolic decompensation.  
Sreedharan & Abdelmalak (2018) discuss that there is ongoing discussion on whether or 
not to proceed with elective surgery when an abnormally high HbA1c is encountered due to lack 
of solid guidance on this topic (p. 585). Currently the ADA does not recommend a certain HbA1c 
threshold above which elective surgery should be postponed. They conclude that current 
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evidence does not support canceling surgeries for a given abnormal HbA1c percentage and that 
a comprehensive perioperative plan be formulated during the preoperative visit. They do note 
however that elective surgery should be delayed in patients who present with evidence of 
diabetic ketoacidosis (DKA).  
Sreedharan & Abdelmalak (2018) note that “association does not mean causation, nor 
does it mean that normalization would result in reversal of that association or improve outcomes, 
as that has not been shown to date” (p. 585). They recognize that HbA1c would take three 
months to reflect glycemic control and therefore measures to improve glycemic control would 
not be reflected immediately. Sreedharan & Abdelmalak state that “from a practical standpoint, 
it may be difficult to cancel elective procedures based on HbA1c criteria understanding that it 
would take about three months to show improvement after pharmacologic and 
nonpharmacologic interventions to improve glycemic control are instituted” (p. 585).  
In a comprehensive literature review by Lopez et al. (2017), findings showed there was 
not sufficient evidence to conclude that higher HbA1c levels in patients with diabetes are 
predictive of postoperative outcomes (p. 1717). They did state “although several studies did find 
an association between higher levels of HbA1c with complications, the overall data were 
insufficient to clearly identify a critical HbA1c level above which the risk of postoperative 
complications becomes prohibitive” (Lopez et al., 2017, p. 1717).  
Using Hemoglobin A1C in Practice 
 Hemoglobin A1C gives clinicians a reflection of a patients preoperative glycemic control. 
It can be used to identify patients at increased risk for postoperative complications so that during 
preoperative evaluation a comprehensive perioperative plan can be formulated. Clinicians can 
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use their judgment in determining whether or not patients with abnormally low or high HbA1c 
levels should proceed with surgery. Currently, there is no guideline as to what level of HbA1c 
should be used in determining when to postpone or cancel surgery. There is evidence in the 
literature supporting that if HbA1c levels are >8%, considerations should be made with the shared 
decision of patient and practitioner (Cancienne et al., 2017; Cheisson et al., 2018; Garg et al., 
2018; Jehan et al., 2017; Lopez et al., 2017; Palermo & Garg, 2019; Reich et al., 2019; Simha & 
Shah, 2019). Additionally, HbA1c levels less than 5% could indicated periods of hypoglycemia, 
which are difficult to assess in patients who are under anesthesia leading to adverse outcomes. 
Considerations should be made for these patients as well and risk vs benefits of surgery should 
be weighed (Cheisson et al., 2018).  
 Mutter & Bryson (2016) offer three possible screening roles for HbA1c. One utility is to 
identify patients at high risk of postoperative hyperglycemia so as to identify those who should 
undergo postoperative glucose monitoring with the goal of preventing SSI. Another benefit is to 
identify patients with elevated HbA1c in whom preoperative intervention to improve glucose 
control might reduce both the risk of SSI and other important postoperative complications. And 
lastly, to identify patients with undiagnosed diabetes who could then avoid long-term end-organ 
complications with this earlier diagnosis and treatment. 
A guideline of the French Society of Anesthesia and Intensive Care Medicine recommend 
postponing surgery for a HbA1c level >9% and <5% (Cheisson et al., 2018). HbA1c that is >9% 
“demonstrates a lack of glycemic control and the patient is thus exposed to acute metabolic 
complications in the perioperative period” (p. 10). For HbA1c <5% it “indicates probable 
recurrent severe hypoglycemia episodes in a patient treated with insulin or hypoglycemic 
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sulphonamides/glinide” (p. 10). They suggest therapeutic adjustments to optimize these patients 
prior to surgery.  
Ngaage et al. (2019) propose the use of some emerging trends in assessing glycemic 
control to better manage glycemic control in patients undergoing surgery as “glycemic control 
represents a modifiable preoperative risk factor in surgery” (p. 1). As HbA1c and plasma glucose 
have traditionally been used as a measure of glycemic control, “several studies show mixed 
results regarding the ability of these conventional measures to predict adverse surgical 
outcomes” (p.1). The use of fructosamine, glycosylated albumin, and 1,5-anhydroglucitol create 
an alternative way to assess glycemic control that reflect the temporal variations in glycemia over 
the preceding days to weeks before surgery (Ngaage et al., 2019). Thus, these measures may 
provide a more accurate measure of glycemic control that can detect deterioration of glycemic 
control earlier and closer to surgery. These alternatives “possess prognostic function alongside 
their use as glycemic indices and have the potential to forecast adverse outcomes and identify 
high-risk patients” (Ngaage et al., 2019, p. 5). Implementing these measures into practice can 
improve preoperative evaluation (Ngaage et al., 2019).  
Learning Points 
1. Diabetes poses a significant risk for postoperative complications including but not limited 
to infection, impaired wound healing, cardiovascular events, venous thromboembolism, 
and mortality (Lopez et al., 2017). Identifying high-risk patients in the preoperative period 
is crucial. 
2. HbA1c is a good measure of glycemic control over the preceding three months. Evidence 
suggests there is an association between poor glycemic control and surgical 
IMPACT OF HEMOGLOBIN A1C ON DIABETIC PATIENTS UNDERGOING ELECTIVE SURGERY
   
13 
complications. Identifying high-risk patients using HbA1c will allow clinicians to optimize 
glycemic control early on (preoperative period) and help formulate comprehensive 
perioperative plans of care with close follow-up and clear discharge instructions to 
improve glucose control so that risk of postoperative complications is reduced. 
3. There is a lack of guidance on whether to proceed with elective surgery when HbA1c is 
out of target range. Literature identifies an increased risk of adverse perioperative 
outcomes when the preoperative HbA1c is <5% or >8%. Patients and their practitioners 
need to discuss risk vs benefit of proceeding with surgery and develop good a 
perioperative plan to reduce risk of complications.  
4. Fructosamine, glycosylated albumin (GA), & 1,5-anhydroglucitol (AG) are emerging 
measures of glycemic control that give clinicians a closer reflection of the temporal 
variability of glycemia due to their shorter half-lives. These emerging measures may 
provide a better utility than HbA1c in forecasting adverse outcomes and identifying high-
risk patients. (Ngaage et al., 2019)  
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